Anhui Sunhere Pharmaceutical Excipients Co Ltd (300452) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.028x

Based on the latest financial reports, Anhui Sunhere Pharmaceutical Excipients Co Ltd (300452) has a cash flow conversion efficiency ratio of 0.028x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥28.48 Million ≈ $4.17 Million USD) by net assets (CN¥1.03 Billion ≈ $151.19 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Anhui Sunhere Pharmaceutical Excipients Co Ltd - Cash Flow Conversion Efficiency Trend (2012–2024)

This chart illustrates how Anhui Sunhere Pharmaceutical Excipients Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Anhui Sunhere Pharmaceutical Excipients total liabilities for a breakdown of total debt and financial obligations.

Anhui Sunhere Pharmaceutical Excipients Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Anhui Sunhere Pharmaceutical Excipients Co Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Akis Gayrimenkul Yatirim Ortakligi AS
IS:AKSGY
0.015x
Kofola CeskoSlovensko as
PR:KOFOL
0.222x
Nexen Tire
KO:002350
0.034x
POET Technologies Inc
V:PTK
-0.157x
Taiwan Semiconductor Co Ltd
TWO:5425
0.054x
Just Dial Limited
NSE:JUSTDIAL
0.024x
Shanghai Wondertek Software Co Ltd
SHG:603189
-0.013x
Bowman Consulting Group Ltd
NASDAQ:BWMN
0.036x

Annual Cash Flow Conversion Efficiency for Anhui Sunhere Pharmaceutical Excipients Co Ltd (2012–2024)

The table below shows the annual cash flow conversion efficiency of Anhui Sunhere Pharmaceutical Excipients Co Ltd from 2012 to 2024. For the full company profile with market capitalisation and key ratios, see 300452 market cap.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 CN¥975.30 Million
≈ $142.72 Million
CN¥118.33 Million
≈ $17.32 Million
0.121x -20.56%
2023-12-31 CN¥935.25 Million
≈ $136.86 Million
CN¥142.84 Million
≈ $20.90 Million
0.153x -9.32%
2022-12-31 CN¥788.62 Million
≈ $115.40 Million
CN¥132.82 Million
≈ $19.44 Million
0.168x +14.51%
2021-12-31 CN¥705.92 Million
≈ $103.30 Million
CN¥103.82 Million
≈ $15.19 Million
0.147x +12.63%
2020-12-31 CN¥655.17 Million
≈ $95.87 Million
CN¥85.55 Million
≈ $12.52 Million
0.131x -1.98%
2019-12-31 CN¥596.57 Million
≈ $87.30 Million
CN¥79.47 Million
≈ $11.63 Million
0.133x -0.59%
2018-12-31 CN¥557.89 Million
≈ $81.64 Million
CN¥74.76 Million
≈ $10.94 Million
0.134x +5.55%
2017-12-31 CN¥500.23 Million
≈ $73.20 Million
CN¥63.51 Million
≈ $9.29 Million
0.127x -7.60%
2016-12-31 CN¥402.70 Million
≈ $58.93 Million
CN¥55.33 Million
≈ $8.10 Million
0.137x +16.99%
2015-12-31 CN¥363.20 Million
≈ $53.15 Million
CN¥42.66 Million
≈ $6.24 Million
0.117x -43.49%
2014-12-31 CN¥177.20 Million
≈ $25.93 Million
CN¥36.83 Million
≈ $5.39 Million
0.208x +19.79%
2013-12-31 CN¥149.23 Million
≈ $21.84 Million
CN¥25.89 Million
≈ $3.79 Million
0.173x -20.42%
2012-12-31 CN¥121.17 Million
≈ $17.73 Million
CN¥26.41 Million
≈ $3.87 Million
0.218x --

About Anhui Sunhere Pharmaceutical Excipients Co Ltd

SHE:300452 China Drug Manufacturers - Specialty & Generic
Market Cap
$484.09 Million
CN¥3.31 Billion CNY
Market Cap Rank
#12700 Global
#3961 in China
Share Price
CN¥14.11
Change (1 day)
+0.00%
52-Week Range
CN¥11.92 - CN¥16.85
All Time High
CN¥25.06
About

Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. research and development, production, and sale of new pharmaceutical excipients in China. The company provides cellulose, starch, povidone, stearic acid, coating powder, resin, food additive, and other products. It also exports its products. Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. was founded in 2001 and is based in Huainan, China.